GlassScriptPhysician profile
Lori Cornelius
NPI 1275906828
$3,470.27
in general payments reported to CMS, 2019-2025
32 companies · $738 in 2025
The $738 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $920 · 2023: $867 · 2024: $791 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,316 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,315.71 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $700.45 | 2021-2025 | Itind System, Soltive |
| Astellas Pharma US INC | $389.07 | 2022-2024 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $374.49 | 2023-2024 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $166.07 | 2023-2025 | Jelmyto |
| Antares Pharma, INC. | $161.55 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $152.67 | 2022-2025 | Erleada |
| 180 Medical, INC. | $146.82 | 2022-2024 | |
| Myriad Genetic Laboratories, INC. | $146.12 | 2021-2025 | Prolaris |
| Medtronic, INC. | $138.60 | 2022 | |
| Urovant Sciences INC | $137.63 | 2022 | |
| Progenics Pharmaceuticals, INC. | $132.52 | 2024 | |
| Coloplast Corp | $116.24 | 2022-2024 | Stenostent, Luja Coude |
| Bayer Healthcare Pharmaceuticals INC. | $111.68 | 2022-2024 | |
| Laborie Medical Technologies Corp. | $98.62 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Vertex Pharmaceuticals Incorporated | $58.17 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $56.51 | 2021-2024 | Rezum Generator |
| Myovant Sciences INC. | $51.44 | 2021-2022 | |
| Blue Earth Diagnostics | $37.78 | 2021-2022 | |
| Convatec INC. | $35.99 | 2023 | |
| Ge Healthcare | $28.54 | 2021 | |
| Endo USA, INC. | $25.49 | 2025 | Xiaflex |
| Tolmar Pharmaceuticals, INC. | $23.45 | 2022 | |
| Palette Life Sciences, INC. | $23.12 | 2022 | |
| Seagen INC. | $22.49 | 2021 | |
| Halozyme INC | $21.82 | 2023 | |
| Dendreon Pharmaceuticals LLC | $20.22 | 2025 | Provenge |
| Procept Biorobotics Corporation | $17.44 | 2022 | |
| Rochester Medical Corporation | $17.14 | 2022 | |
| Koelis INC. | $15.72 | 2023 | |
| Abc Home Medical Supply, INC. | $15.17 | 2022 | |
| Pfizer INC. | $13.68 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $13.57 | 2024 | Onglyza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Cornelius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.